Related references
Note: Only part of the references are listed.Lentigo Maligna: Clinical Presentation and Appropriate Management
Helena Iznardo et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2020)
Treatment of squamous cell carcinoma of the eyelid with imiquimod 5% cream
Manpreet Singh et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2019)
A Retrospective Cohort Study on Patients with Lentigo Maligna Melanoma
Selina M. Frohlich et al.
DERMATOLOGY (2019)
Comparison of surgical margins for lentigo maligna versus melanoma in situ
Joy H. Kunishige et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy
Flurin L. Brand et al.
DERMATOLOGY (2019)
Guidelines of care for the management of primary cutaneous melanoma
Susan M. Swetter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment
Darryl C. K. S. Tio et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Lentigo Maligna-Challenges, Observations, Imiquimod, Confocal Microscopy, and Personalized Treatment
Scott W. Fosko et al.
JAMA DERMATOLOGY (2018)
Rate of Recurrence of Lentigo Maligna Treated With Off-label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision
Jessica M. Donigan et al.
JAMA DERMATOLOGY (2018)
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
Gamze Ozturk Karabulut et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2017)
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures
D. Tio et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis
Megan A. Rowlands et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma
Jeffrey S. Moyer et al.
JAMA DERMATOLOGY (2017)
Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study
J. R. Marsden et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Periocular Melanoma In Situ Treated With Imiquimod
Maxwell D. Elia et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2016)
Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate
Gudula Kirtschig et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Combination Topical Therapy for Conjunctival Primary Acquired Melanosis With Atypia and Periocular Lentigo Maligna
Emily M. Bratton et al.
CORNEA (2015)
Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study
Anita Toender et al.
MELANOMA RESEARCH (2014)
Surgical margins for melanoma in situ
Joy H. Kunishige et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions
Paul S. Cannon et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids
Verena Prokosch et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Periocular lentigo maligna treated with imiquimod
Jennifer O'Neill et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2011)
Topical Imiquimod for Periocular Lentigo Maligna
Hakan Demirci et al.
OPHTHALMOLOGY (2010)
Conjunctival Melanoma: A New Clinical and Therapeutical Approach
M. Rodriguez-Martin et al.
CASE REPORTS IN DERMATOLOGY (2010)
Recurrence of Lentigo Maligna and Development of Invasive Melanoma after Treatment of Lentigo Maligna with Imiquimod
Courtney S. Woodmansee et al.
DERMATOLOGIC SURGERY (2009)
Imiquimod:: mode of action
M. P. Schoen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study
Raveewan Choontanom et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)
Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma
MA Blasi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000
SM Swetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Bowen disease of the eyelid successfully treated with imiquimod
PA Brannan et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Topical imiquimod immunotherapy in the management of lentigo maligna
AM Powell et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma
R Malhotra et al.
OPHTHALMOLOGY (2003)
Histologic evaluation of lentigo maligna with permanent sections: Implications regarding current guidelines
N Agarwal-Antal et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type
ZS Tannous et al.
HUMAN PATHOLOGY (2000)
Share Paper
